Contents of this document
- Profit increase from higher revenue¥675 million
- Profit increase from foreign exchange effects¥358 million
- Higher personnel expenses¥-110 million
- Higher other SG&A expenses¥-133 million
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Second quarter of the fiscal year ending December 2026 |
| Net Sales | ¥19,517 million (YoY +14.0%) |
| Operating profit | ¥3,526 million (YoY +29.0%) |
| Ordinary income | ¥3,533 million (YoY +35.0%) |
| Net income | ¥2,361 million (YoY +34.0%) |
| Full-year earnings forecast | Net Sales ¥33,820 million / Operating profit ¥3,800 million / Ordinary income ¥3,700 million / Profit attributable to owners of the parent ¥2,410 million |
| Progress against full-year forecast | Net Sales 58% / Operating profit 93% / Ordinary income 95% / Profit attributable to owners of the parent 98% |
| Breakdown of Factors Affecting the Change | Factors Profit increase from higher revenue / Amount ¥675 million, Factors Profit increase from foreign exchange effects / Amount ¥358 million, Factors Higher personnel expenses / Amount ¥-110 million, Factors Higher other SG&A expenses / Amount ¥-133 million |
Items this document does not state (22)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Domestic sales of agricultural chemicals, fertilizers and biostimulants, overseas sales, and the performance of overseas affiliates remained strong, while foreign exchange effects increased profit. Selling, general and administrative expenses also increased, mainly due to higher personnel expenses and other costs.